Highlighting its biological utility, the network reveals that across numerous samples the genes Drd1 and Gpr6, which are individually known to play roles in Parkinson’s disease (PD) and are being pursued as therapeutic targets, are cross-expressed in the striatum, hinting at their joint function in the central anatomical locus in PD pathophysiology. This evidence concerns the gene GPR6 and Parkinson disease.